Begin main content

Call for Patient Input: Orkambi

Published on: January 24, 2018
Result type: News

CADTH has received the following drug submission(s) and/or notice(s) of pending submission(s). If you are interested in providing patient input, please click on “Submit.” For information about the patient input process or for additional instructions, please see the Patient Input page of our website.


Brand name Generic name Manufacturer Indication(s)
Orkambi lumacaftor/ivacaftor Vertex Pharmaceuticals (Canada) Incorporated Cystic Fibrosis, F508del CFTR mutation in patients 6 years and older
Project Number Call for patient input Patient input deadline Submit patient input
SR0559-000 2018-01-24 2018-03-15 Submit